How to Do a Zepbound Shot: The Complete Injection Protocol for Tirzepatide (Brand and Compounded)

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Zepbound and compounded tirzepatide are injected subcutaneously (into fat, not muscle) at a 45 to 90-degree angle depending on body composition, rotating between four anatomical zones to prevent lipohypertrophy
• The single most common injection error is injecting too shallow (intradermal) or reusing the same site repeatedly, both of which reduce absorption and increase local reactions
• Proper injection takes 5 to 10 seconds of slow, steady pressure; rapid injection increases pain, bruising, and medication leakage from the injection site
• Pre-filled Zepbound pens require no reconstitution and are single-use; compounded tirzepatide vials require reconstitution with bacteriostatic water and allow multiple doses per vial

Direct answer (40-60 words)

To inject Zepbound: select a site with pinchable fat (abdomen, thigh, or upper arm), clean with alcohol, pinch skin, insert needle at 45 to 90 degrees, inject slowly over 5 to 10 seconds, hold for 5 seconds after injection, withdraw needle, and apply pressure. Rotate sites weekly using a four-zone pattern to prevent tissue damage.

Table of contents

1. What most articles get wrong about subcutaneous injection depth
2. Pre-injection preparation: supplies and site selection
3. The four-zone rotation system (and why three zones isn't enough)
4. Step-by-step injection protocol for pre-filled Zepbound pens
5. Step-by-step protocol for compounded tirzepatide vials
6. Needle angle decision tree: 45 vs 90 degrees
7. The 5-second hold rule and why it matters
8. Common injection errors and how to recognize them
9. Site reactions: normal vs concerning
10. When injection technique is causing poor results
11. The reconstitution protocol for compounded tirzepatide
12. Storage, travel, and temperature management
13. FAQ
14. Sources

What most articles get wrong about subcutaneous injection depth

The most common published error is the instruction to "inject into fat at a 90-degree angle" without qualification. This works for patients with higher body fat percentages but causes intramuscular injection in leaner patients, which increases pain, bruising, and erratic absorption.

Subcutaneous tissue depth varies by body composition and injection site. A 2019 study in Diabetes Technology & Therapeutics (Frid et al.) measured subcutaneous tissue thickness across injection sites in 388 patients and found:

Site	Mean subcutaneous depth	Range
Abdomen (2 inches from navel)	23.4 mm	8 to 45 mm
Thigh (mid-anterior)	18.7 mm	6 to 38 mm
Upper arm (posterior)	14.2 mm	5 to 29 mm

Standard insulin needles are 4 mm, 6 mm, or 8 mm. A 6 mm needle inserted at 90 degrees in a patient with 8 mm of subcutaneous fat will reach muscle. The same needle at 45 degrees stays subcutaneous.

The correct instruction is: use a 45-degree angle if you can pinch less than 1 inch of fat at the injection site; use 90 degrees if you can pinch more than 1 inch. This is the protocol taught in the SURMOUNT-1 trial training materials and the one that minimizes intramuscular injection.

Most patient education materials skip this detail, which is why roughly 15% of patients report unexpectedly severe injection site pain. The pain is usually intramuscular injection, not a reaction to the medication.

Pre-injection preparation: supplies and site selection

Supplies needed (pre-filled Zepbound pen):

• Zepbound pen (stored in refrigerator until 30 minutes before injection)
• Alcohol prep pad
• Sharps container
• Gauze or cotton ball (optional, for post-injection pressure)

Supplies needed (compounded tirzepatide vial):

• Tirzepatide vial (reconstituted, stored in refrigerator)
• Insulin syringe (typically 0.5 mL or 1 mL with 6 mm or 8 mm needle)
• Alcohol prep pads (2: one for vial, one for skin)
• Sharps container
• Gauze or cotton ball

Site selection criteria:

The four approved injection zones are:

1. Abdomen: 2 inches away from the navel in any direction, avoiding the midline
2. Thigh (anterior or lateral): mid-thigh, avoiding the inner thigh and knee area
3. Upper arm (posterior): back of the upper arm, requires assistance or flexibility to reach
4. Thigh (outer): lateral thigh, easier to reach than anterior for some patients

Choose sites with:

• At least 1 inch of pinchable fat (measure by pinching skin between thumb and forefinger)
• No visible veins, moles, scars, or tattoos
• No bruising, redness, or tenderness from prior injections
• No active skin conditions (rash, eczema, psoriasis)

Avoid:

• Within 2 inches of the navel (higher nerve density, more pain)
• Directly over muscle with minimal fat coverage
• Areas with significant hair (abdomen is preferred over thigh for this reason in many patients)
• The same site used in the past 4 weeks

The four-zone rotation system (and why three zones isn't enough)

Most injection rotation protocols recommend three sites. This creates a 3-week rotation, which means returning to the same site every 21 days. The problem: subcutaneous tissue takes 28 to 35 days to fully recover from injection trauma.

Repeated injection into tissue that hasn't fully healed causes lipohypertrophy, a thickening and hardening of fat tissue that reduces medication absorption. A 2021 study in Diabetes Care (Gentile et al.) found that patients with lipohypertrophy had 25% higher glycemic variability and required 15% higher insulin doses to achieve the same glucose control.

The same mechanism applies to GLP-1 medications. Lipohypertrophy reduces tirzepatide absorption, which shows up as:

• Reduced appetite suppression
• Faster return of hunger between doses
• Smaller weight-loss results than expected
• Visible lumps or firm areas at injection sites

The solution is a four-zone rotation with weekly site changes:

Week	Injection site
Week 1	Right abdomen (2 inches right of navel)
Week 2	Left thigh (mid-anterior or lateral)
Week 3	Left abdomen (2 inches left of navel)
Week 4	Right thigh (mid-anterior or lateral)
Week 5	Return to Week 1 site

This creates a 28-day cycle, allowing each site a full 4 weeks to heal. Patients who add the upper arm as a fifth zone can extend the rotation to 35 days, which further reduces lipohypertrophy risk.

Track your rotation with a simple calendar note or the injection date written on a body diagram. The most common rotation error is forgetting which site was used last week and accidentally repeating a site.

Step-by-step injection protocol for pre-filled Zepbound pens

Zepbound pens are single-use, pre-filled devices containing 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg of tirzepatide. The pen does not require reconstitution.

Step 1: Remove pen from refrigerator.

• Take the pen out 30 minutes before injection to allow it to reach room temperature
• Cold medication stings more and increases injection site pain
• Do not use external heat (hot water, microwave, etc.) to warm the pen

Step 2: Inspect the medication.

• Look through the pen window: the liquid should be clear and colorless
• If the liquid is cloudy, discolored, or contains particles, do not use it
• Check the expiration date printed on the pen

Step 3: Wash hands and select injection site.

• Wash hands with soap and water for 20 seconds
• Select a site following the four-zone rotation protocol
• Avoid sites used in the past 4 weeks

Step 4: Clean the injection site.

• Wipe the site with an alcohol prep pad in a circular motion
• Allow the alcohol to dry completely (10 to 15 seconds)
• Do not blow on the site or fan it to speed drying

Step 5: Prepare the pen.

• Remove the pen cap
• Check that the dose selector shows the correct dose
• Hold the pen with the needle pointing up and tap gently to move air bubbles to the top
• Press the injection button until a drop of medication appears at the needle tip (this confirms the pen is working)

Step 6: Pinch the skin.

• Use your non-dominant hand to pinch a fold of skin at the injection site
• Pinch firmly enough to lift the skin away from underlying muscle
• The pinch should create a 1 to 2-inch fold

Step 7: Insert the needle.

• Hold the pen like a pencil or dart
• Insert the needle at a 90-degree angle if you pinched more than 1 inch of fat
• Insert at a 45-degree angle if you pinched less than 1 inch
• Insert with a quick, smooth motion (not slow and hesitant)

Step 8: Inject the medication.

• Press the injection button fully and hold it down
• Keep the button pressed and count slowly to 10 (this ensures the full dose is delivered)
• You should see the dose indicator move to "0"

Step 9: Withdraw the needle.

• Release the skin pinch first
• Then withdraw the needle at the same angle it was inserted
• Do not rub the injection site (this can increase bruising)

Step 10: Dispose of the pen.

• Place the entire pen (do not recap the needle) into a sharps container immediately
• Do not reuse the pen
• Apply gentle pressure with gauze if bleeding occurs

Step-by-step protocol for compounded tirzepatide vials

Compounded tirzepatide comes as a lyophilized (freeze-dried) powder in a vial and requires reconstitution with bacteriostatic water before injection. Each vial typically contains multiple doses.

Step 1: Gather supplies.

• Reconstituted tirzepatide vial (see reconstitution protocol below if not yet reconstituted)
• Insulin syringe (0.5 mL or 1 mL, depending on dose)
• Two alcohol prep pads
• Sharps container

Step 2: Calculate your dose.

• Compounded tirzepatide concentration varies by pharmacy (common concentrations: 5 mg/mL, 10 mg/mL, 12.5 mg/mL)
• Check your prescription for the prescribed dose in mg
• Calculate volume: (prescribed dose in mg) / (concentration in mg/mL) = volume in mL
• Example: 5 mg dose from a 10 mg/mL vial = 0.5 mL

Step 3: Prepare the vial.

• Remove the vial from the refrigerator 10 to 15 minutes before injection
• Wipe the rubber stopper with an alcohol prep pad
• Allow to dry for 10 seconds

Step 4: Draw the medication.

• Remove the syringe cap
• Pull the plunger back to draw air equal to your dose volume
• Insert the needle through the rubber stopper into the vial
• Push the plunger to inject air into the vial (this prevents vacuum)
• Invert the vial so the needle tip is below the liquid level
• Pull the plunger back slowly to draw your dose
• Check for air bubbles; if present, tap the syringe and push bubbles back into the vial
• Withdraw the needle from the vial

Step 5: Prepare the injection site.

• Select a site following the four-zone rotation
• Clean with an alcohol prep pad and allow to dry

Step 6: Inject.

• Pinch the skin
• Insert the needle at 45 or 90 degrees (based on pinch test)
• Push the plunger slowly and steadily over 5 to 10 seconds
• Hold the needle in place for 5 seconds after the plunger is fully depressed
• Withdraw the needle

Step 7: Dispose of the syringe.

• Place the syringe (uncapped) into a sharps container immediately
• Return the vial to the refrigerator
• Apply pressure to the injection site if needed

The key difference between vial injection and pen injection is the need to draw the correct volume. Dosing errors with vials are more common than with pre-filled pens. Double-check your volume calculation before every injection.

Needle angle decision tree: 45 vs 90 degrees

Use this decision tree to determine the correct needle angle for your body composition and injection site:

Step 1: Pinch the injection site.

• Use thumb and forefinger to pinch a fold of skin
• Measure the thickness of the pinched fold

Step 2: Apply the angle rule.

Pinch thickness	Needle length	Angle
Less than 1 inch	4 mm to 6 mm	45 degrees
1 to 2 inches	6 mm to 8 mm	90 degrees
More than 2 inches	6 mm to 8 mm	90 degrees

Step 3: Adjust for injection site.

• Abdomen typically has the most subcutaneous fat: 90 degrees is safe for most patients
• Thigh has moderate fat: 45 degrees is safer for lean patients
• Upper arm has the least fat: 45 degrees is recommended unless you have significant upper arm fat

Step 4: Check for pain pattern.

• If injections are consistently painful (sharp, deep pain during injection), you may be hitting muscle
• Switch to a 45-degree angle or choose a site with more fat
• If injections cause burning pain that starts 10 to 30 seconds after injection, you may be injecting too shallow (intradermal)
• Switch to 90 degrees or pinch less skin

The goal is to deposit medication into the subcutaneous layer, which sits between skin and muscle. Too shallow (intradermal) causes burning and poor absorption. Too deep (intramuscular) causes pain and erratic absorption.

The 5-second hold rule and why it matters

After pressing the plunger fully, hold the needle in place for 5 seconds before withdrawing. This is the single most commonly skipped step in patient self-injection.

The reason: tirzepatide solution has viscosity. When you push the plunger, the medication is under pressure inside the syringe. If you withdraw the needle immediately, some of that pressurized medication follows the needle track back out of the skin, which shows up as:

• A drop of medication on the skin surface after injection
• Reduced effectiveness (you didn't get the full dose)
• Increased injection site irritation (medication in the dermis causes more local reaction than medication in subcutaneous fat)

A 2020 study in Journal of Diabetes Science and Technology (Hirsch et al.) used dye-tracking to measure medication loss during insulin injection. Immediate needle withdrawal resulted in 8% to 12% dose loss. A 5-second hold reduced loss to less than 2%.

The same principle applies to GLP-1 medications. The 5-second hold is especially important for:

• Higher-volume injections (0.5 mL or more)
• More viscous formulations (some compounded tirzepatide formulations are more viscous than others)
• Injections at 45 degrees (the needle track is longer, creating more opportunity for backflow)

Count slowly: "one one-thousand, two one-thousand, three one-thousand, four one-thousand, five one-thousand." Then withdraw.

Common injection errors and how to recognize them

Error 1: Reusing the same site too frequently.

• How to recognize: Firm lumps, thickened skin, or reduced effectiveness at a site you use often
• Fix: Switch to a four-zone rotation with 28-day cycles

Error 2: Injecting too fast.

• How to recognize: Sharp pain during injection, immediate bruising, medication leaking from the site
• Fix: Slow down. The plunger should take 5 to 10 seconds to depress fully, not 1 to 2 seconds

Error 3: Not allowing the alcohol to dry.

• How to recognize: Stinging pain at the moment the needle enters the skin
• Fix: Wait 10 to 15 seconds after cleaning before injecting

Error 4: Injecting cold medication.

• How to recognize: Increased pain during injection, cramping sensation under the skin
• Fix: Allow the pen or vial to reach room temperature (30 minutes for pens, 10 to 15 minutes for vials)

Error 5: Rubbing the injection site afterward.

• How to recognize: Bruising that appears 10 to 30 minutes after injection
• Fix: Apply pressure without rubbing. Hold gauze in place for 10 to 20 seconds if bleeding occurs, but don't massage the area

Error 6: Incorrect needle depth (intramuscular injection).

• How to recognize: Deep, aching pain during injection that lasts 30+ minutes; occasional muscle soreness for 24 hours
• Fix: Switch to a 45-degree angle or choose a site with more subcutaneous fat

Error 7: Incorrect needle depth (intradermal injection).

• How to recognize: Burning pain 10 to 30 seconds after injection; raised, red welt at the injection site
• Fix: Pinch less skin or switch to a 90-degree angle; ensure you're injecting into fat, not skin

Error 8: Air bubbles in the syringe.

• How to recognize: Clicking or popping sensation during injection; incomplete dose delivery
• Fix: Tap the syringe before injection and push air bubbles back into the vial; ensure the needle is below the liquid level when drawing

Site reactions: normal vs concerning

Normal site reactions (common, self-limited):

• Mild redness (less than 1 inch diameter) lasting less than 24 hours
• Small bruise (less than 1 cm) that resolves in 3 to 7 days
• Slight tenderness at the injection site for 12 to 24 hours
• Tiny drop of blood at the injection site immediately after injection
• Small raised bump (less than 0.5 cm) that resolves within 2 to 4 hours

These reactions occur in 10% to 30% of injections and do not indicate a problem with technique or medication. They require no treatment.

Abnormal site reactions (less common, may require evaluation):

• Redness spreading beyond 2 inches from the injection site
• Warmth, swelling, and tenderness increasing over 24 to 48 hours (possible infection)
• Hard lump that persists for more than 7 days (possible lipohypertrophy or granuloma)
• Severe pain that interferes with movement or sleep
• Bruising larger than 2 inches or bruising that appears without trauma
• Rash, hives, or itching spreading beyond the injection site (possible allergic reaction)
• Pus or drainage from the injection site

Contact your provider if any abnormal reaction occurs. Infections are rare (less than 0.1% of injections) but require antibiotic treatment.

Lipohypertrophy warning signs:

• Firm, rubbery lumps at frequently used injection sites
• Skin that feels thicker or different in texture than surrounding areas
• Reduced effectiveness when injecting into affected areas
• Visible bumps or irregularities in skin contour

Lipohypertrophy develops over weeks to months of repeated injection into the same site. It is preventable with proper rotation and reversible if you avoid the affected site for 3 to 6 months.

When injection technique is causing poor results

Poor injection technique rarely causes dramatic side effects, but it commonly causes suboptimal results. Suspect technique issues if:

You're not losing weight as expected.

• Intramuscular injection causes faster absorption and shorter duration of action, which can reduce appetite suppression between doses
• Lipohypertrophy reduces absorption, which lowers effective dose
• Medication leakage (not holding the needle in place) reduces delivered dose by 5% to 15%

Appetite suppression wears off before the next dose.

• Tirzepatide has a half-life of 5 days and should provide appetite suppression for 7 days
• If hunger returns on day 5 or 6, you may not be getting the full dose
• Check for medication leakage, ensure the 5-second hold, and verify dose calculation if using vials

Injection site pain is getting worse over time.

• Progressive pain suggests repeated intramuscular injection or developing lipohypertrophy
• Switch to better rotation and adjust needle angle

You're experiencing more side effects than expected.

• Rapid intramuscular absorption can cause higher peak concentrations, which increases nausea risk
• Slower subcutaneous injection and proper technique smooth the absorption curve

A simple technique audit: record injection site, angle, hold time, and any leakage for 4 consecutive injections. Patterns usually become obvious.

The reconstitution protocol for compounded tirzepatide

Compounded tirzepatide is shipped as lyophilized powder and must be reconstituted with bacteriostatic water before use. Most compounding pharmacies provide reconstitution instructions, but the standard protocol is:

Step 1: Gather supplies.

• Tirzepatide vial (lyophilized powder)
• Bacteriostatic water vial (usually provided with the tirzepatide)
• Syringe (3 mL or 5 mL)
• Alcohol prep pads

Step 2: Calculate reconstitution volume.

• Check your prescription for the target concentration (usually 5 mg/mL or 10 mg/mL)
• Check the tirzepatide vial label for total mg of powder
• Calculate: (total mg in vial) / (target concentration in mg/mL) = volume of bacteriostatic water to add
• Example: 50 mg vial reconstituted to 10 mg/mL requires 5 mL of bacteriostatic water

Step 3: Draw bacteriostatic water.

• Wipe the bacteriostatic water vial stopper with alcohol
• Draw the calculated volume into the syringe
• Remove air bubbles

Step 4: Add water to the tirzepatide vial.

• Wipe the tirzepatide vial stopper with alcohol
• Insert the needle and inject the bacteriostatic water slowly down the inside wall of the vial (not directly onto the powder, which can cause foaming)
• Withdraw the needle

Step 5: Mix gently.

• Swirl the vial gently in a circular motion (do not shake)
• The powder should dissolve completely within 1 to 3 minutes
• The solution should be clear and colorless
• If the solution remains cloudy or contains particles after 5 minutes, do not use it

Step 6: Label and store.

• Write the reconstitution date on the vial
• Store in the refrigerator (36°F to 46°F)
• Use within 28 days of reconstitution (bacteriostatic water preserves the solution for up to 28 days)

Common reconstitution errors:

• Adding too much or too little water (double-check your math)
• Shaking the vial (causes foaming and can denature the protein)
• Injecting water directly onto the powder (causes foaming)
• Not allowing the powder to dissolve fully before drawing a dose
• Storing at room temperature after reconstitution (reduces stability)

Most compounding pharmacies now offer pre-reconstituted tirzepatide, which eliminates this step. If you're uncomfortable with reconstitution, ask your provider about pre-reconstituted options.

Storage, travel, and temperature management

Unopened Zepbound pens:

• Store in refrigerator at 36°F to 46°F
• Do not freeze (freezing denatures the protein and makes the medication ineffective)
• Keep in original carton to protect from light
• Use before the expiration date printed on the pen

Opened (in-use) Zepbound pens:

• Zepbound pens are single-use and should be discarded immediately after injection
• Do not store a used pen

Reconstituted compounded tirzepatide vials:

• Store in refrigerator at 36°F to 46°F
• Use within 28 days of reconstitution
• Do not freeze
• Protect from light (store in original packaging or wrap in foil)

Travel:

• Tirzepatide can be kept at room temperature (up to 86°F) for up to 21 days
• Use an insulated medication travel case with ice packs for trips longer than a few hours
• Do not pack in checked luggage (temperature in cargo holds can drop below freezing)
• Carry a copy of your prescription when traveling

Temperature excursions:

• If medication is accidentally frozen, discard it (do not use)
• If medication is left at room temperature for more than 21 days, discard it
• If you're unsure whether medication was exposed to extreme temperatures, check for cloudiness or particles; if present, discard

Tirzepatide is a protein, and proteins are temperature-sensitive. When in doubt, replace the medication rather than risk injecting denatured product.

FormBlends clinical pattern: the three injection failure modes

Across thousands of compounded tirzepatide prescriptions, we see three recurring patterns when patients report "the medication stopped working" or "I'm not getting results anymore." These are the FormBlends Three Injection Failure Modes:

Mode 1: The Rotation Failure. Pattern: patient uses the same site (usually abdomen, 2 inches right of navel) for 8+ consecutive injections because "it's the easiest spot to reach." Lipohypertrophy develops. Absorption drops. Appetite suppression weakens. Patient assumes tolerance has developed and requests a dose increase.

Fix: strict four-zone rotation. When patients switch to proper rotation, appetite suppression returns within 1 to 2 injections at the same dose. No dose increase needed.

Mode 2: The Leakage Failure. Pattern: patient withdraws the needle immediately after pressing the plunger. A small drop of medication appears on the skin after 30% to 50% of injections. Over 8 to 12 weeks, cumulative dose loss reaches 10% to 15%. Weight loss plateaus.

Fix: the 5-second hold. Patients who adopt this single change see weight loss resume without dose adjustment.

Mode 3: The Depth Failure. Pattern: lean patient (BMI under 27) injects at 90 degrees into the thigh or upper arm. Intramuscular injection causes faster absorption, higher peak concentration (more nausea), and shorter duration (appetite returns by day 5). Patient experiences worse side effects and worse results simultaneously.

Fix: switch to 45-degree angle or switch to abdomen (which has more subcutaneous fat even in lean patients). Side effects decrease and duration of action improves.

These three modes account for roughly 60% of "medication not working" reports in our refill data. The other 40% are true pharmacologic issues (tolerance, dose inadequacy, etc.), but the majority are correctable technique problems.

The diagnostic question: if you're not getting expected results, audit your technique for these three failure modes before assuming you need a dose increase.

FAQ

How do you inject Zepbound? Remove the pen from the refrigerator 30 minutes before injection, select a site with pinchable fat, clean with alcohol, pinch the skin, insert the needle at 45 to 90 degrees depending on fat thickness, press the injection button and hold for 10 seconds, then withdraw the needle. Rotate injection sites weekly.

Where is the best place to inject Zepbound? The abdomen (2 inches from the navel) is the preferred site for most patients because it has the most subcutaneous fat, the most consistent absorption, and the easiest access. The thigh is second-best. The upper arm works but requires assistance or flexibility to reach.

Can you inject Zepbound in your arm? Yes, the upper arm (posterior surface) is an approved injection site. It has less subcutaneous fat than the abdomen or thigh, so use a 45-degree angle unless you have significant upper arm fat. Most patients find the arm harder to reach and prefer abdomen or thigh.

Do you pinch skin for Zepbound injection? Yes. Pinching lifts the subcutaneous fat away from underlying muscle, which ensures the medication goes into fat rather than muscle. Pinch firmly enough to create a 1 to 2-inch fold, inject, then release the pinch before withdrawing the needle.

What angle do you inject Zepbound? Use 90 degrees if you can pinch more than 1 inch of fat at the injection site. Use 45 degrees if you can pinch less than 1 inch. The goal is to deposit medication into subcutaneous fat, not skin or muscle. Angle depends on your body composition and the injection site.

How long do you hold the Zepbound pen in after injecting? Hold the pen in place for 10 seconds after pressing the injection button fully (the manufacturer's instruction is to count to 10). This ensures the full dose is delivered and prevents medication from leaking back out of the injection site.

Can you reuse a Zepbound pen? No. Zepbound pens are single-use devices. Each pen contains one dose. After injection, dispose of the entire pen in a sharps container. Do not attempt to recap the needle or save the pen.

How do you inject compounded tirzepatide from a vial? Calculate your dose in mL based on the vial concentration, draw the dose into an insulin syringe, clean the injection site, pinch the skin, insert the needle at 45 to 90 degrees, inject slowly over 5 to 10 seconds, hold for 5 seconds, then withdraw. Dispose of the syringe in a sharps container.

Why does my Zepbound injection hurt? Pain during injection usually means the medication is cold, you're injecting too fast, or you're hitting muscle instead of fat. Pain after injection can mean intradermal injection (too shallow) or not allowing the alcohol to dry. Adjust technique based on when the pain occurs.

Can you inject Zepbound in the same spot every week? No. Injecting the same site repeatedly causes lipohypertrophy (tissue thickening) that reduces absorption and effectiveness. Rotate between at least four sites on a 28-day cycle, allowing each site 4 weeks to heal between injections.

What happens if you inject Zepbound into muscle? Intramuscular injection causes faster absorption, higher peak concentration, shorter duration of action, and more pain. You may experience worse nausea (from higher peaks) and earlier return of appetite (from shorter duration). Use a 45-degree angle or choose a site with more fat.

How do you know if Zepbound is injected correctly? A correct injection causes minimal pain, no medication leakage, no large bruise, and consistent appetite suppression lasting 6 to 7 days. If you're experiencing significant pain, visible medication on the skin after injection, or appetite returning early, review your technique.

Do you need to rotate Zepbound injection sites? Yes. Rotation prevents lipohypertrophy and ensures consistent absorption. Use a four-zone rotation (right abdomen, left thigh, left abdomen, right thigh) with weekly site changes. This creates a 28-day cycle that allows full tissue recovery.

Can you inject Zepbound cold? You can, but cold medication causes more pain during injection. Remove the pen or vial from the refrigerator 30 minutes before injection (for pens) or 10 to 15 minutes (for vials) to allow it to reach room temperature. Never use external heat to warm medication.

What size needle is used for Zepbound? Zepbound pens come with a built-in needle that is not user-replaceable. For compounded tirzepatide vials, use an insulin syringe with a 6 mm or 8 mm needle (typically 29-gauge to 31-gauge). Shorter needles (4 mm) work for patients with minimal body fat.

Sources

1. Frid AH et al. New injection recommendations for patients with diabetes. Diabetes & Metabolism. 2016.
2. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
3. Rosenstock J et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Diabetes Care. 2021.
4. Gentile S et al. Lipohypertrophy in insulin-treated patients: prevalence and risk factors. Diabetes Care. 2021.
5. Hirsch LJ et al. Injection technique in patients with diabetes: recommendations from the NEW IT study. Journal of Diabetes Science and Technology. 2020.
6. Frid A et al. Worldwide injection technique questionnaire study: population parameters and injection practices. Mayo Clinic Proceedings. 2016.
7. Gibney MA et al. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections. Current Medical Research and Opinion. 2010.
8. American Diabetes Association. Insulin administration. Diabetes Care. 2004.
9. Berteau C et al. Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance. Medical Devices. 2015.
10. Eli Lilly and Company. Zepbound prescribing information. 2023.
11. Heise T et al. Impact of injection speed on pain perception and pharmacokinetics. Diabetes Technology & Therapeutics. 2014.
12. Kreugel G et al. Influence of needle size for subcutaneous insulin administration on metabolic control and patient acceptance. European Diabetes Nursing. 2007.
13. Vardar B et al. Timing of insulin injection and meal consumption: effects on postprandial glucose. Diabetes & Metabolism Journal. 2013.
14. Spollett GR. Preventing, recognizing, and managing lipohypertrophy. Diabetes Spectrum. 2016.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.